162 related articles for article (PubMed ID: 14624428)
21. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis.
Kim YH; Lee BK; Park DW; Park KH; Choi BR; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2006 Dec; 98(11):1451-4. PubMed ID: 17126648
[TBL] [Abstract][Full Text] [Related]
22. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent.
Cosgrave J; Melzi G; Corbett S; Biondi-Zoccai GG; Babic R; Airoldi F; Chieffo A; Sangiorgi GM; Montorfano M; Michev I; Carlino M; Colombo A
Am Heart J; 2007 Mar; 153(3):354-9. PubMed ID: 17307411
[TBL] [Abstract][Full Text] [Related]
23. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial.
Alfonso F; Pérez-Vizcayno MJ; Hernandez R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Mantilla R; Morís C; Cequier A; Sabaté M; Escaned J; Moreno R; Bañuelos C; Suárez A; Macaya C;
J Am Coll Cardiol; 2006 Jun; 47(11):2152-60. PubMed ID: 16750678
[TBL] [Abstract][Full Text] [Related]
24. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
25. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
[TBL] [Abstract][Full Text] [Related]
26. Treatment of restenosis after bare-metal and drug-eluting stenting of an aorto-ostial lesion: challenges associated with excessive stent overhang.
Kunadian B; Vijayalakshmi K; de Belder MA
J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):744-7. PubMed ID: 17700411
[TBL] [Abstract][Full Text] [Related]
27. Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents.
Corbett SJ; Cosgrave J; Melzi G; Babic R; Biondi-Zoccai GG; Godino C; Morici N; Airoldi F; Michev I; Montorfano M; Sangiorgi GM; Bonizzoni E; Colombo A
Eur Heart J; 2006 Oct; 27(19):2330-7. PubMed ID: 16952923
[TBL] [Abstract][Full Text] [Related]
28. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
29. Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries.
Lee CW; Park DW; Lee BK; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2006 Feb; 97(4):506-11. PubMed ID: 16461047
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
[TBL] [Abstract][Full Text] [Related]
31. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation.
Lee SH; Park JS; Shin DG; Kim YJ; Hong GR; Kim W; Shim BS
Am J Cardiol; 2007 Aug; 100(4):627-30. PubMed ID: 17697818
[TBL] [Abstract][Full Text] [Related]
32. Restenosis of a sirolimus drug-eluting stent: aorto-ostial involvement of the proximal right coronary artery.
Applegate RJ; Draughn T; Yarbrough WD; Little WC
Catheter Cardiovasc Interv; 2006 Mar; 67(3):391-5. PubMed ID: 16475190
[TBL] [Abstract][Full Text] [Related]
33. Oral rapamycin in the treatment of diffuse proliferative in-stent restenosis in a patient with small reference vessel.
Rodriguez AE; Fernández Pereira C; Rodríguez Alemparte M
J Invasive Cardiol; 2003 Sep; 15(9):515-8. PubMed ID: 12947212
[No Abstract] [Full Text] [Related]
34. Severe intimal hyperplasia after sirolimus eluting stent deployment: evaluation by optical coherence tomography.
Gupta R; Raffel OC; Jang IK
Heart; 2007 Jun; 93(6):754. PubMed ID: 17502657
[No Abstract] [Full Text] [Related]
35. [Drug-eluting stents in complex lesions].
Lefèvre T
Ann Cardiol Angeiol (Paris); 2003 Jun; 52(3):176-83. PubMed ID: 12938571
[TBL] [Abstract][Full Text] [Related]
36. [In-stent restenosis: which indications for drug-eluting stent?].
Eltchaninoff H; Tron C; Cribier A
Ann Cardiol Angeiol (Paris); 2003 Jun; 52(3):198-9. PubMed ID: 12938576
[TBL] [Abstract][Full Text] [Related]
37. Multiple ulcerations in plaque behind stent struts resulting in late stent malapposition after gamma brachytherapy for in-stent restenosis.
Hirose M; Kobayashi Y; Moses JW
J Invasive Cardiol; 2003 Sep; 15(9):530-2. PubMed ID: 12947216
[TBL] [Abstract][Full Text] [Related]
38. Underexpansion of sirolimus-eluting stents: incidence and relationship to delivery pressure.
Cheneau E; Satler LF; Escolar E; Suddath WO; Kent KM; Weissman NJ; Waksman R; Pichard AD
Catheter Cardiovasc Interv; 2005 Jun; 65(2):222-6. PubMed ID: 15900554
[TBL] [Abstract][Full Text] [Related]
39. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis.
Fujii K; Mintz GS; Kobayashi Y; Carlier SG; Takebayashi H; Yasuda T; Moussa I; Dangas G; Mehran R; Lansky AJ; Reyes A; Kreps E; Collins M; Colombo A; Stone GW; Teirstein PS; Leon MB; Moses JW
Circulation; 2004 Mar; 109(9):1085-8. PubMed ID: 14993129
[TBL] [Abstract][Full Text] [Related]
40. Sirolimus-eluting stents: the novel application of basic science to coronary artery disease.
Foley DP
Ir Med J; 2002 Oct; 95(9):283. PubMed ID: 12470008
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
